Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

This study is currently recruiting participants.

Study NCT00199628. Last updated on March 10, 2006. Information provided by University Hospital, Limoges

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Official Title ^†

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Brief Summary

Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can induce severe anemia of the fetus.

The investigators recently proved that incompatibility between mother and child can concern an organ leading to a tissular alloimmunization. For example, neonatal membranous glomerulonephritis (a kidney disease) can result from this mechanism.

The purpose of this network is to detect and study neonatal diseases induced by tissular fetomaternal alloimmunization. The detection of these diseases will be performed by the mother's serum analysis.

Detailed Description

Study Phase

Study Type ^†

Observational

Study Design ^†

Longitudinal, Defined Population, Prospective Study

Primary Outcome Measure ^†

Secondary Outcome Measure ^†

Condition ^†

Glomerulonephritis, Membranous
Neonatal Diseases and Abnormalities
Hemochromatosis

Intervention ^†

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Recruiting

Enrollment ^†

100

Start Date ^†

September 2005

Completion Date

Eligibility Criteria ^†

Inclusion Criteria:

Mothers having a child suffering from:

Neonatal membranous glomerulonephritis
Unexplained neonatal tubular defect
Unexplained thrombotic microangiopathy
Neonatal hemochromatosis

Exclusion Criteria:

Any cause explaining the child's disease

Gender

Female

Ages

Accepts Healthy Volunteers

Contacts ^††

Contact: Vincent Guigonis, MD

+33(0)555 056 358

vincent.guigonis@chu-limoges.fr

Location Countries ^†

France

Administrative Information Fields

NCT ID ^†

NCT00199628

Organization ID

I05001

Secondary IDs ^††

Study Sponsor ^†

University Hospital, Limoges

Collaborators ^††

Investigators ^†

Principal Investigator:

Vincent Guigonis, MD

Department of Pediatrics, Limoges University Hospital

Information Provided By

University Hospital, Limoges

Verification Date

September 2005

First Received Date ^†

September 14, 2005

Last Updated Date

March 10, 2006

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.